OBJECTIVE: Mutations in the Progranulin gene (PGRN) recently have been discovered to be associated with frontotemporal dementia (FTD) linked to 17q21 without identified MAPT mutations. The range of mutations of PGRN that can result in the FTD phenotype and the clinical presentation of patients with PGRN mutations have yet to be determined. METHODS: In this study, we examined 84 FTD patients from families not known previously to have illness linked to chromosome 17 for identified PGRN and MAPT mutations and sequenced the coding exons and the flanking intronic regions of PGRN. We compared the prevalence, clinical characteristics, magnetic resonance imaging and 18-fluoro-deoxyglucose positron emission tomography results, and neuropsychological testing of patients with the PGRN R493X mutation with those patients without identified PGRN mutations. RESULTS: We discovered a new PGRN mutation (R493X) resulting in a stop codon in two patients. This was the only PGRN mutation identified in ou...
|Autori:||HUEY ED; GRAFMAN J; WASSERMANN EM; PIETRINI P; TIERNEY MC; GHETTI B; SPINA S; BAKER M; HUTTON M; ELDER JW; BERGER SL; HEFLIN KA; HARDY J; MOMENI P|
|Titolo:||Characteristics of frontotemporal dementia patients with a Progranulin mutation|
|Anno del prodotto:||2006|
|Digital Object Identifier (DOI):||10.1002/ana.20969|
|Appare nelle tipologie:||1.1 Articolo in rivista|